Alnylam Pharmaceuticals, Inc. (ALNY) News

Latest headlines that mention ALNY, newest first · each headline opens the original publisher

ALNY quote

Last price: $231.83
Day change: -0.94%
Next earnings: 2026-10-29

Quote & chart Expected move Insider trading IV rank history

ALNY headlines

last 30 days

Investing.com 5d ago

Alnylam EVP Bryan Supran sells $398,855 in shares

General T3ALNY

Motley Fool 6d ago

Alnylam vs. Ionis: Here's the Better Bad-News Buy

The sell-offs for both of these beaten-down biotech stocks appear to be overdone.

General T3ALNY IONS

Seeking Alpha News 18d ago

Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform

General T2ALNY

Motley Fool 18d ago

18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right.

Wall Street expects an even bigger rebound for this beaten-down biotech stock.

General T3ALNY

Seeking Alpha News 20d ago

Alnylam Needs Stronger Amvuttra Execution To Justify More Upside

General T2ALNY

Seeking Alpha News 29d ago

Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control Transcript

General T2ALNY

Seeking Alpha News 29d ago

Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Zilebesiran and the Potential of RNAi Therapeutics for Continuous Blood Pressure Control - Slideshow

General T2ALNY

Also mentioned with ALNY

30d

IONS1

Headlines that tag both tickers

ALNY news alerts

Get an alert by email or push when a new headline mentions ALNY.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.